Your browser doesn't support javascript.
loading
Cognitive testing to evaluate revisions to the Vaccine Adverse Event Reporting System (VAERS) reporting form.
Suragh, Tiffany A; Miller, Elaine R; Hibbs, Beth F; Winiecki, Scott K; Zinderman, Craig; Shimabukuro, Tom T.
Afiliación
  • Suragh TA; Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States. Electronic address: tsuragh@cdc.gov.
  • Miller ER; Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States.
  • Hibbs BF; Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States.
  • Winiecki SK; Safe Use Team, Professional Affairs and Stakeholder Engagement Staff, Center for Drug Evaluation and Research, US Food and Drug Administration, United States.
  • Zinderman C; Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, United States.
  • Shimabukuro TT; Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States.
Vaccine ; 35(18): 2295-2297, 2017 04 25.
Article en En | MEDLINE | ID: mdl-28351735
ABSTRACT

INTRODUCTION:

The Vaccine Adverse Event Reporting System (VAERS) is the spontaneous (passive) reporting system CDC and FDA use to monitor vaccine safety. We used cognitive testing to evaluate proposed revisions to the current VAERS form.

METHODS:

We conducted in-person cognitive interviews with 22 volunteers to evaluate proposed revisions in a prototype VAERS 2.0 form (new VAERS form). We analyzed data using thematic analysis.

RESULTS:

Repeating themes included preferences for brevity, simplicity and clarity; features to minimize time requirements and facilitate ease of completion; logical ordering of questions by topic and importance; and visual cues like color-coded highlighting. Interviews identified instances of discordance between the intended meaning questions (from the perspective of CDC and FDA) and interpretation by volunteers.

CONCLUSIONS:

Cognitive testing yielded useful information to guide further revisions of the VAERS form. Cognitive testing can be an effective tool for public health programs interested in developing surveys and reporting forms.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vigilancia de Productos Comercializados / Vacunas / Sistemas de Registro de Reacción Adversa a Medicamentos Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vigilancia de Productos Comercializados / Vacunas / Sistemas de Registro de Reacción Adversa a Medicamentos Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article